Cell Culture Media Market size is anticipated to cross USD 54 Billion by the end of 2035, growing at a CAGR of 19% during the forecast period, i.e., 2023-2035. In the year 2022, the industry size of the cell culture media was over USD 7 Billion.The growth of the market can be attributed to the increasing advancements in the field of molecular biology along with the rising advances in biological science accelerating the bio revolution globally. For instance, researchers worldwide estimate that biological applications alone are expected to exhibit a direct positive economic impact of almost USD 4 trillion a year globally over the next 10 to 20 years.
The cell culture media is vital to the culture environment. It provides those components that essentially support cell growth and function. Further, as the environmental conditions in cell culture, including osmotic pressure and pH, can be regulated with the formulation of media, a variety of cell culture media formulations have been developed to support a wide range of cell types and experimental applications. Hence, with the growing global burden of diseases, as well as the rising focus and expenditure on research and development proficiencies concerning cell-based research, cell culture media is predicted to present the potential for cell culture media market expansion over the projected period. For instance, according to the World Health Organization, ischemic heart disease alone was responsible for the largest
Growth Drivers
Challenges
|
Base Year |
2022 |
|
Forecast Year |
2023-2035 |
|
CAGR |
~19% |
|
Base Year Market Size (2022) |
~ USD 7 Billion |
|
Forecast Year Market Size (2035) |
~ USD 54 Billion |
|
Regional Scope |
|
Type (Liquid Media, Semi-Solid Media, Solid Media)
The global cell culture media market is segmented and analyzed for demand and supply by type into liquid media, semi-solid media, and solid media. Out of the three types of cell culture media, the liquid segment is estimated to gain the largest market share of about ~38% in the year 2035. The growth of the segment can be attributed to the rising investment in the pharmaceutical sector as well as the increasing collaborations amongst major players as well as R&D in the field of life sciences for novel drug development and therapeutic research. For instance, recently in March 2023, Nucleus Biologics, The Cell Performance Company, a leading provider of custom cell culture media solutions for the cell and gene therapy industry, and Stoic Bio, a provider of sustainable technology for cell media manufacturing, in a joint effort to accelerate high-quality therapies to market, announced plans for a supply agreement with the Center for Breakthrough Medicines (CBM), leading contract development and manufacturing organization (CDMO). The mission of CDMO is to save lives by accelerating the development and manufacture of advanced therapies.
End-user (Hospitals & Diagnostic Laboratories, Pharmaceutical)
The global cell culture media market is also segmented and analyzed for demand and supply by end-user into hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies, research & academic institutes, and others. Amongst these segments, the pharmaceutical & biotechnology segment is expected to garner a significant share of around ~46% in the year 2035. The rising share of sales of biotechnology drugs worldwide which amounted to over USD 400 billion in 2022 is anticipated to boost the segment growth. On the other hand, the research & academics segment is projected to witness a massive CAGR during the forecast period, owing to the increasing research and development proficiencies in the direction of cell culture media along with the rising advancement in stem cell therapies. This, as a result, is also anticipated to create numerous opportunities for the growth of the segment in the coming years.
Our in-depth analysis of the global market includes the following segments:
|
By Type |
|
|
By Product |
|
|
By Application |
|
|
By End User |
|
North American Market Forecast
The cell culture media market in North America is projected to be the largest with a share of about ~35% by the end of 2035. The growth of the market can be attributed majorly to the growing investment in the biopharmaceutical sector as well as growing advancements in the field of gene therapy, tissue engineering, production of vaccines, antibiotics, and artificial hormones. As per findings, federal research funding, in the field of human genetics and genomics research reached about USD 3.3 billion in 2019. Moreover, the rising number of organ transplants as well as the increasing popularity of processes such as in vitro fertilization, and cryo-preservation is also anticipated to boost the regional market growth.
APAC Market Statistics
The Asia Pacific cell culture media market is estimated to be the second largest, registering a share of about ~27% by the end of 2035. The growth of the market can be attributed majorly to the rising investment in the field of biotechnology and the growing investigations of basic cell biology together with the rising approvals for cell culture-based vaccines and therapeutics. Moreover, the rising prevalence of immune diseases along with increasing incidence owing to diseases such as cancer that necessitates the replication of disease mechanisms, besides investigating the toxicity of novel drug compounds is also anticipated to boost the market growth in the region.
Europe Market Forecast
Further, the cell culture media market in Europe, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2035. The growth of the market in the region can primarily be attributed to the growing geriatric population as well as the surge in demand for personalized medicine, along with the expanding R&D activities for various chronic diseases. Additionally, the presence, as well as the expansion of some major players in the region, is further expected to boost regional market growth.
Thermo Fisher Scientific Inc., announced the expansion of cell culture media manufacturing site in Grand Island, New York, to meet increasing global demand for cell culture media used in the manufacturing of new vaccines and biologics. It’s a dry powder media manufacturing facility that provides the redundant capacity to support a global supply of media needed for the development and commercial manufacturing of vaccines and biological therapies.
Merck KGaA, a leading science and technology company, announced the completion of a USD 2.8 million expansion to its Irvine biopharmaceutical production facility which is Merck’s only location where both liquid and powder cell culture media are manufactured.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?